GZMB and neoplasm: In support of this hypothesis, phenotypic characterization of the tumour-infiltrating CD8+ cells from both treated and distant tumours revealed a more robust upregulation of the markers indicative of effector function (that is, ICOS and Granzyme B; Fig. 3h).